No. 182. Active surveillance for s mall r enal m asses : Outcomes within an Australian outpatient s etting. Dr Gideon A Blecher, Dr Sam S Farah, Prof Mark Frydenberg Department of Urology, Southern Health. Melbourne. Australia. Posters Proudly Supported by: . Introduction
Active surveillance for small renal masses: Outcomes within an Australian outpatient setting
Dr Gideon A Blecher, Dr Sam S Farah, Prof Mark Frydenberg
Department of Urology, Southern Health. Melbourne. Australia
Posters Proudly Supported by:
Small renal masses (SRMs) are frequently encountered due to the increasing utilisation of abdominal imaging. The rate of metastases is low and a minority will be benign. Active surveillance (AS) has therefore emerged as a potential management option.
A retrospective case series of all patients presenting with SRM to an outpatient Urological practice were reviewed.
Inclusion criteria: Patients with a SRM, initial size less than 4cm
Exclusion criteria: Lesions of initial size > 4cm, hyperdense cyst.
AS appears to be a safe method of managing patients with SRM. A minority of those undergoing AS will require further investigation (ie: biopsy) or definitive management as a result of growth or patient choice.
Rising incidence of renal cell cancer in the United States.Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. JAMA. 1999 May 5; 281(17):1628-31.
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006 Feb;175(2):425-31.
Thank you to Mr M.Chong for providing some of the initial data